Published in Mol Carcinog on June 24, 2016
Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry. Oncotarget (2017) 0.75
Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol (2016) 0.75
A Review of Pulmonary Toxicity of Electronic Cigarettes In The Context of Smoking: A Focus On Inflammation. Cancer Epidemiol Biomarkers Prev (2017) 0.75
XCMS Online: a web-based platform to process untargeted metabolomic data. Anal Chem (2012) 3.24
Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta (1998) 2.47
Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 2.25
Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol (1999) 1.87
Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med (1995) 1.82
Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg (2006) 1.67
Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study. PLoS One (2008) 1.40
Glutamate, at the interface between amino acid and carbohydrate metabolism. J Nutr (2000) 1.13
Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem (2006) 1.11
Separation strategies for untargeted metabolomics. J Sep Sci (2011) 1.11
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther (1998) 1.10
Urine menthol as a biomarker of mentholated cigarette smoking. Cancer Epidemiol Biomarkers Prev (2010) 1.04
Disposition kinetics and effects of menthol. Clin Pharmacol Ther (1999) 1.03
Lysophosphatidylcholine: an enigmatic lysolipid. Am J Physiol Lung Cell Mol Physiol (2005) 1.03
Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res (2014) 1.00
Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med (2013) 0.98
Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol (2005) 0.97
Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chem Res Toxicol (2009) 0.97
Sex differences in coronary artery disease: pathological observations. Atherosclerosis (2015) 0.97
Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res (2011) 0.97
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. Eur J Biochem (1998) 0.95
PDE4 inhibitors in COPD--a more selective approach to treatment. Respir Med (2004) 0.95
Sensory properties of menthol and smoking topography. Tob Induc Dis (2011) 0.94
Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clin Chim Acta (2012) 0.89
Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med (2000) 0.87
Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS. J Proteome Res (2013) 0.86
Gender differences in the association between smoking and dyslipidemia: 2005 Korean National Health and Nutrition Examination Survey. Clin Chim Acta (2011) 0.84
Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. Arterioscler Thromb Vasc Biol (2000) 0.84
Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease. Am J Clin Nutr (2006) 0.82
Clinical significance of phospholipase A2 group IIA (PLA2G2A) expression in primary resected esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci (2013) 0.82
Metabolomics using GC-TOF-MS followed by subsequent GC-FID and HILIC-MS/MS analysis revealed significantly altered fatty acid and phospholipid species profiles in plasma of smokers. J Chromatogr B Analyt Technol Biomed Life Sci (2014) 0.82
Developmental cigarette smoke exposure: liver proteome profile alterations in low birth weight pups. Toxicology (2012) 0.82
Developmental cigarette smoke exposure: kidney proteome profile alterations in low birth weight pups. Toxicology (2012) 0.81
Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity. Acta Derm Venereol (2004) 0.81
Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Histopathology (2011) 0.80
Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition. J Cell Physiol (2010) 0.80
Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study. BMJ Open (2014) 0.80
Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion. Mol Med Rep (2011) 0.79
Atypical plasma lipid profile in cancer patients: cause or consequence? Biochimie (2014) 0.78
NMR- and MS-based metabolomics: various organ responses following naphthalene intervention. Mol Biosyst (2014) 0.77
Providing a Science Base for the Evaluation of Tobacco Products. Tob Regul Sci (2015) 0.76
Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases. Atherosclerosis (1975) 0.76
PDE inhibitors currently in early clinical trials for the treatment of asthma. Expert Opin Investig Drugs (2014) 0.76
Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Mol Carcinog (2015) 0.77
Menthol smokers: metabolomic profiling and smoking behavior. Cancer Epidemiol Biomarkers Prev (2016) 0.75